Lumacaftor/ Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction
Số trang: 8
Loại file: pdf
Dung lượng: 1.10 MB
Lượt xem: 5
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Treatment of patients with Cystic Fibrosis homozygous for the Phe508del gene, with Lumacaftor /Ivacaftor (LUM/IVA) improves outcomes in patients with FEV1 > 40% predicted. We set out to observe the most sensitive clinical measure that would change with treatment in terms of exercise capacity or lung function in adults with severe lung disease as defined by an FEV1 < 40% predicted when clinically stable.
Nội dung trích xuất từ tài liệu:
Lumacaftor/ Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction
Nội dung trích xuất từ tài liệu:
Lumacaftor/ Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction
Tìm kiếm theo từ khóa liên quan:
BMC Pulmonary Medicine Cystic fibrosis Six minute walk test Lung function Lung transplantationTài liệu liên quan:
-
7 trang 23 0 0
-
Clinical impact of cardiovascular disease on patients with bronchiectasis
7 trang 23 0 0 -
8 trang 22 0 0
-
10 trang 20 0 0
-
9 trang 20 0 0
-
6 trang 19 0 0
-
Efect of periodontal therapy on COPD outcomes: A systematic review
16 trang 17 0 0 -
11 trang 17 0 0
-
Diseases and Disorders Anthrax
112 trang 17 0 0 -
7 trang 17 0 0